Home
Neurogene

Neurogene Market Share Analysis for June 2026

We were founded on a passionate belief that innovation in gene therapy can bring treatment options to patients with complex neurological diseases—patients who are waiting with unmet needs and often overlooked.

Industry: N/A

Domainneurogene.com

Year Founded2018

Employees51 - 200

Annual Revenue$25M - $50M

Neurogene

Neurogene (including company regionals)

neurogene.com

See more website traffic and engagement information

Neurogene Revenue up to June 2026 is 25M - 50M

revenue generated by Neurogene top domains

Neurogene top domains revenue over 3 years

Revenue for Neurogene top domains

neurogene.com25M - 50M

See more with Sales Intelligence

Total visits to Neurogene's top domains

Understand Neurogene market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

neurogene.com6.3K

See more with Sales Intelligence

Avg. visit duration in Neurogene's top domains

Analyze Neurogene engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

neurogene.com00:00:34

See more with Sales Intelligence

Avg. pageviews on Neurogene's top domains

See how Neurogene keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

neurogene.com1.88

See more with Sales Intelligence

Neurogene top competitors by domain

Top similar sites in June 2026, ranked by their affinity

centogene.comCompany NameCentogeneEmployees501 - 1000HQGermany, RostockAnnual revenue$200M - $500MTotal visits19.5KHealth > Health Conditions and Concerns

Top technologies used by Neurogene

These are the website technologies, by industry, used by Neurogene top domains

Payment & Currencies (11)

Cart Functionality

Advertising (9)

DoubleClick

eCommerce (5)

Swap

Widget (4)

Twemoji

More Technologies

12

See all

News & Signals from Neurogene

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNeurogene Inc. hired Christy Shafer as Chief Commercial Officer on Apr 20th '26.US clinical-stage biotech Neurogene (Nasdaq: NGNE) today announced the appointment of Christy Shafer as chief commercial officer and the appointment of Christine Mikail to its board of directors.

NewsNeurogene Inc. attended event Stifel 2026 Virtual CNS Forum on Mar 11th '26.Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the Stifel 2026 Virtual CNS Forum.

NewsNeurogene Inc. launches monitoring and treatment system.Neurogene has introduced a new monitoring and treatment system for its adeno-associated virus (AAV) gene therapy after a Rett syndrome patient died during a clinical trial.